CN116705224A - Display method, device, equipment and medium of medication scheme information - Google Patents
Display method, device, equipment and medium of medication scheme information Download PDFInfo
- Publication number
- CN116705224A CN116705224A CN202310518684.3A CN202310518684A CN116705224A CN 116705224 A CN116705224 A CN 116705224A CN 202310518684 A CN202310518684 A CN 202310518684A CN 116705224 A CN116705224 A CN 116705224A
- Authority
- CN
- China
- Prior art keywords
- information
- medicine
- medication
- drug
- medication scheme
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 820
- 229940079593 drug Drugs 0.000 title claims abstract description 533
- 238000000034 method Methods 0.000 title claims abstract description 61
- 230000015654 memory Effects 0.000 claims description 25
- 230000006870 function Effects 0.000 claims description 19
- 238000004590 computer program Methods 0.000 claims description 12
- 230000000694 effects Effects 0.000 claims description 11
- 206010059866 Drug resistance Diseases 0.000 claims description 6
- 230000005540 biological transmission Effects 0.000 claims description 4
- 231100000331 toxic Toxicity 0.000 claims description 4
- 230000002588 toxic effect Effects 0.000 claims description 4
- 230000001960 triggered effect Effects 0.000 claims description 2
- 208000024891 symptom Diseases 0.000 description 27
- 229960003022 amoxicillin Drugs 0.000 description 20
- LSQZJLSUYDQPKJ-NJBDSQKTSA-N amoxicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 LSQZJLSUYDQPKJ-NJBDSQKTSA-N 0.000 description 20
- LSQZJLSUYDQPKJ-UHFFFAOYSA-N p-Hydroxyampicillin Natural products O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)C(N)C1=CC=C(O)C=C1 LSQZJLSUYDQPKJ-UHFFFAOYSA-N 0.000 description 20
- 229960000282 metronidazole Drugs 0.000 description 18
- VAOCPAMSLUNLGC-UHFFFAOYSA-N metronidazole Chemical compound CC1=NC=C([N+]([O-])=O)N1CCO VAOCPAMSLUNLGC-UHFFFAOYSA-N 0.000 description 18
- 238000010801 machine learning Methods 0.000 description 12
- SUBDBMMJDZJVOS-UHFFFAOYSA-N 5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole Chemical compound N=1C2=CC(OC)=CC=C2NC=1S(=O)CC1=NC=C(C)C(OC)=C1C SUBDBMMJDZJVOS-UHFFFAOYSA-N 0.000 description 9
- 201000007100 Pharyngitis Diseases 0.000 description 9
- 229960000381 omeprazole Drugs 0.000 description 9
- 206010011224 Cough Diseases 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 238000010586 diagram Methods 0.000 description 6
- 201000010099 disease Diseases 0.000 description 5
- 230000001225 therapeutic effect Effects 0.000 description 5
- 238000004891 communication Methods 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 238000012545 processing Methods 0.000 description 4
- 230000002411 adverse Effects 0.000 description 3
- 238000013527 convolutional neural network Methods 0.000 description 3
- 230000008878 coupling Effects 0.000 description 3
- 238000010168 coupling process Methods 0.000 description 3
- 238000005859 coupling reaction Methods 0.000 description 3
- 208000035475 disorder Diseases 0.000 description 3
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 206010017964 Gastrointestinal infection Diseases 0.000 description 2
- 206010024971 Lower respiratory tract infections Diseases 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 206010057190 Respiratory tract infections Diseases 0.000 description 2
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 2
- 230000003044 adaptive effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 208000019836 digestive system infectious disease Diseases 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 230000007803 itching Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000003062 neural network model Methods 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010061182 Genitourinary tract infection Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 208000022506 anaerobic bacteria infectious disease Diseases 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- 238000013475 authorization Methods 0.000 description 1
- 230000019771 cognition Effects 0.000 description 1
- 238000011262 co‐therapy Methods 0.000 description 1
- 238000013500 data storage Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000000820 nonprescription drug Substances 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 238000009512 pharmaceutical packaging Methods 0.000 description 1
- 210000003800 pharynx Anatomy 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P90/00—Enabling technologies with a potential contribution to greenhouse gas [GHG] emissions mitigation
- Y02P90/30—Computing systems specially adapted for manufacturing
Abstract
The embodiment of the specification provides a method, a device, equipment and a medium for displaying medication scheme information. The method comprises the following steps: receiving medicine tracing code information; the method comprises the steps of sending a medication scheme obtaining request carrying medicine tracing code information to a server, wherein the medication scheme obtaining request is used for requesting the server to obtain target medication scheme information according to standard information of medicines corresponding to the medicine tracing code information; and displaying the received target medication scheme information sent by the server. According to the embodiment of the specification, the medicine purchased by the patient is determined through the medicine tracing code information corresponding to the medicine, and then the target medication scheme information of the medicine is obtained according to the standard information of the medicine.
Description
Technical Field
The embodiment in the specification relates to the field of internet medical treatment, in particular to a method, a device, equipment and a medium for displaying medication scheme information.
Background
Today, when a patient purchases a drug at a physical pharmacy, a pharmacy salesperson will typically recommend a medication regimen for the patient based on the patient's description of the symptoms of the patient and the medical knowledge that the pharmacy salesperson has. For example, a patient describing his own symptoms as cough and fever, a pharmacy sales person may recommend a regimen to the patient that includes an antitussive and an antipyretic.
However, due to individual differences between patients, the level of medical knowledge of different pharmacy sales personnel varies, and the medication proposal provided to the patient based on the patient's own symptom description may not be applicable to the actual condition of the patient, and the accuracy of the medication proposal is not high.
Therefore, the technical problem of low accuracy of the drug proposal provided by the salesperson of the pharmacy exists in the related art.
Disclosure of Invention
In view of this, various embodiments in the present specification are directed to providing a method, apparatus, device, and medium for displaying medication information, so as to improve the accuracy of medication advice provided by pharmacy sales to some extent.
One embodiment of the present disclosure provides a method for displaying medication plan information, which is applied to a client; the method comprises the following steps: receiving medicine tracing code information; wherein, the medicine tracing code information corresponds to the medicine; sending a medication scheme acquisition request carrying the medicine tracing code information to a server, wherein the medication scheme acquisition request is used for requesting the server to acquire target medication scheme information according to the standard information of the medicine corresponding to the medicine tracing code information; the standard information is used for describing basic information of the medicine; the target medication scheme information comprises associated medicine information with a specified association relation with the standard information; the appointed association relation is used for indicating that the associated medicine corresponding to the associated medicine information can be applied to the appointed treatment purpose together with the medicine corresponding to the medicine traceability code information; and displaying the received target medication scheme information sent by the server.
One embodiment of the present disclosure provides a method for sending medication plan information, which is applied to a server; the method comprises the following steps: receiving a medication scheme acquisition request carrying medication traceability code information sent by a client; wherein, the medicine tracing code information corresponds to the medicine; acquiring target medication scheme information according to the label information of the medicine corresponding to the medicine tracing code information; the standard information is used for describing basic information of the medicine; the target medication scheme information comprises associated medicine information with a specified association relation with the standard information; the appointed association relation is used for indicating that the associated medicine corresponding to the associated medicine information can be applied to the appointed treatment purpose together with the medicine corresponding to the medicine traceability code information; and sending the target medication scheme information to the client.
One embodiment of the present disclosure provides a display device of medication information, applied to a client, where the device includes: the receiving module is used for receiving the medicine tracing code information; wherein, the medicine tracing code information corresponds to the medicine; the sending module is used for sending a medication scheme acquisition request carrying the medicine tracing code information to a server so as to request the server to acquire target medication scheme information according to the standard information of the medicine corresponding to the medicine tracing code information; the standard information is used for describing basic information of the medicine; the target medication scheme comprises associated medicine information with a specified association relation with the standard information; the appointed association relation is used for indicating that the associated medicine corresponding to the associated medicine information can be applied to the appointed treatment purpose together with the medicine corresponding to the medicine traceability code information; the display module is used for displaying the received target medication scheme information sent by the server.
One embodiment of the present specification provides a device for transmitting medication information, applied to a server, the device including: the receiving module is used for receiving a medication scheme acquisition request carrying medicine traceability code information sent by the client; wherein, the medicine tracing code information corresponds to the medicine; the acquisition module is used for acquiring target medication scheme information according to the standard information of the medicine corresponding to the medicine tracing code information; the standard information is used for describing basic information of the medicine; the target medication scheme information comprises associated medicine information with a specified association relation with the standard information; the appointed association relation is used for indicating that the associated medicine indicated by the associated medicine information can be applied to the appointed treatment purpose together with the medicine corresponding to the medicine traceability code information; and the sending module is used for sending the target medication scheme information to the client.
The present description embodiment proposes a computer device comprising a memory storing a computer program and a processor implementing the method according to the above embodiment when the processor executes the computer program.
The present description provides a computer-readable storage medium having stored thereon computer program instructions which, when executed by a processor, implement the method described in the above embodiments.
According to the embodiments provided by the specification, medicines purchased by patients are determined through medicine traceability code information corresponding to the medicines, target medication scheme information comprising related medicines which can be applied to specified treatment purposes together with the medicines is acquired according to standard information of the medicines, and the target medication scheme information is displayed to sales staff of a pharmacy. Because the drug tracing code information and the standard information of the drug are standardized information, firstly, the unique drug is determined based on the drug tracing code information, and then, the accuracy of the drug proposal provided by the salesperson of the pharmacy can be improved to a certain extent based on the target drug proposal obtained by the standard information of the drug.
Drawings
Fig. 1 is a multi-terminal interaction schematic diagram of a display system for medication information according to an embodiment of the present disclosure.
Fig. 2 is a schematic diagram of a client display interface in a display system of medication information according to an embodiment of the present disclosure.
Fig. 3 is a schematic architecture diagram of a display system for medication information according to an embodiment of the present disclosure.
Fig. 4 is a flow chart of a method for displaying medication information according to an embodiment of the present disclosure.
Fig. 5 is a flowchart of a method for sending medication information according to an embodiment of the present disclosure.
Fig. 6 is a schematic diagram of a display device for medication information according to an embodiment of the present disclosure.
Fig. 7 is a schematic diagram of a device for transmitting medication information according to an embodiment of the present disclosure.
Fig. 8 is a schematic diagram of a computer device according to an embodiment of the present disclosure.
Detailed Description
SUMMARY
In the related art, there may be two kinds of medicine purchase scenarios at a physical pharmacy.
The first medicine purchase scenario may be for a patient to first consult a pharmacy sales person with a medication proposal before purchasing a medicine, the pharmacy sales person providing the patient with the medication proposal, and the patient then purchasing the medicine according to the medication proposal. In this scenario, the pharmacy sales personnel recommend medication for the patient based mainly on the patient's description of his own symptoms and the medical knowledge that the pharmacy sales personnel own. However, due to differences in constitution, cognition and course of disease among different patients, there may be a large difference in descriptions of self symptoms for patients who actually suffer from the same disease, for example, both patients suffer from cold, one patient may describe self symptoms as cough, and the other patient may describe self symptoms as headache. Meanwhile, the descriptions of the symptoms of the patients who actually suffer from different diseases may be substantially the same, for example, one patient suffers from a cold, one patient suffers from pharyngitis, and both patients may describe the symptoms of the patients as cough. In addition, the medical knowledge of the sales staff of different pharmacies may be greatly different due to the difference of education level and working experience among the sales staff of different pharmacies. Specifically, after the patient describes the symptoms of the patient, the salesman with higher medical knowledge level may further ask the patient for other conditions, and comprehensively judge the condition of the patient according to all the information fed back by the patient and provide the medication proposal. While a pharmacy sales person with a lower level of medical knowledge may only provide medication advice based on the symptoms described by the patient. For example, after the patient describes his own symptoms as cough, a salesperson in a pharmacy with a higher level of medical knowledge may further ask the patient about the cough, whether the symptom duration, the symptom severity, other symptoms, etc. are accompanied, comprehensively judge that the patient may have a cold according to the information fed back by the patient, and provide a medication proposal suitable for the cold. While a lower medical knowledge level pharmacy sales person may only provide the patient with a medication regimen advice appropriate for the cough based on the symptom of the cough.
In this scenario, both the patient's description of the symptoms themselves and the medical knowledge possessed by the pharmacy sales personnel are fuzzy information that is difficult to evaluate or measure by standard, and the medication provided by the pharmacy sales personnel based on the fuzzy information may be difficult to adapt to the actual condition of the patient with low accuracy.
The second medicine purchasing scene can be that the patient knows the medication scheme according to the medical knowledge possessed by the patient or channels such as network inquiry and consultation to other people, and then the medicine is directly purchased in a pharmacy according to the medication scheme. In this scenario, the pharmacy sales personnel will typically not provide medication advice to the patient, but will simply settle the cost of purchasing the medication for the patient. If the patient forms a medication regimen according to the medical knowledge of the patient or consults with others to learn the medication regimen, the learned medication regimen may be difficult to be applicable to the actual condition of the patient because the medical knowledge of the patient or the other consulted by the patient is fuzzy information and has large difference. If the patient uses the network to inquire and learn the medication scheme, the authenticity of the network information is difficult to determine, and the patient inquires based on the fuzzy information of the symptoms of the patient, the accuracy of the learned medication scheme is not high, and even the toxic and side effects of medicines in the medication scheme can aggravate the symptoms of the patient.
Therefore, it is necessary to provide a display method of a medication scheme, by receiving medication trace code information and sending a medication scheme acquisition request carrying the medication trace code information to a server, so as to request the server to acquire target medication scheme information according to the standard information of the medication corresponding to the medication trace code information, and then displaying the target medication scheme information fed back by the server to a sales person in a pharmacy, so that the medication purchased by a patient is determined according to the medication trace code information corresponding to the medication, and then the target medication scheme information including the related medication which can be applied to a specified treatment purpose together with the medication is acquired according to the standard information of the medication.
Scene example
The drugs described in the embodiments of the present specification may all be over-the-counter drugs over the efficacy period. Can be used for treating common mild diseases or chronic diseases. The present embodiment does not specifically limit the medicine.
One embodiment of the present disclosure provides an application scenario example of a presentation system for medication regimen information. The presentation system of the medication intake scheme information can include a server and a client. The client may be used for executing the display method of the medication scheme information, and the server may be used for executing the sending method of the medication scheme information. The user of the client may be a physical pharmacy sales person.
Please refer to fig. 1. Under the application scene, after a patient purchases one or more medicines in a physical pharmacy, the patient goes to a pharmacy cashier to settle the purchased medicines. For example, the patient purchased "amoxicillin" from manufacturer 1. The drug salesman can scan the drug traceability code on the amoxicillin packaging box through the scanning equipment, so that the client receives the drug traceability code information. After receiving the medicine tracing code information, the client can build a medicine scheme acquisition request carrying the medicine tracing code information and send the medicine scheme acquisition request carrying the medicine tracing code information to the server.
The server can extract attribute data representing the multidimensional attribute of the medicine from the pharmaceutical knowledge graph in advance to generate a specified medication scheme information set. After receiving the medication scheme acquisition request, the server can send a standard information acquisition request to a standard information base according to the medicine traceability code information carried by the request so as to acquire the standard information of the amoxicillin. After receiving the standard information of the amoxicillin, the server can obtain target medication scheme information corresponding to the indication information based on the indication information in the standard information of the amoxicillin and matching the indication information in the appointed medication scheme information set. Specifically, the target medication regimen information may include associated medication information that is applied to the specified therapeutic purpose with the "amoxicillin". For example, the indication information in the standard information of the amoxicillin is "upper and lower respiratory tract infection, genitourinary tract infection and gastrointestinal tract infection", so that the related medicine applicable to the "upper and lower respiratory tract infection" can comprise the "metronidazole" produced by the manufacturer 2, and the related medicine applicable to the "gastrointestinal tract infection" can comprise the "metronidazole" produced by the manufacturer 2 and the "omeprazole" produced by the manufacturer 3. The target medication scheme obtained by the server in the appointed medication scheme information set in a matching way can comprise a medication scheme I of the amoxicillin and the metronidazole produced by the manufacturer 2, a medication scheme II of the amoxicillin, the metronidazole produced by the manufacturer 2 and the omeprazole produced by the manufacturer 3, and the server can send the medication scheme information corresponding to the medication scheme I and the medication scheme II to the client as target medication scheme information.
The client may obtain inventory data for all of the medicines that the pharmacy may sell. After receiving the target medication scheme information, the client can judge whether the inventory of the associated medicine is sufficient according to the inventory data of the associated medicine corresponding to the associated medicine information in the target medication scheme information, and display the received target medication scheme information on a display interface of the client to a salesperson of a pharmacy under the condition that the inventory data of the associated medicine meets the specified quantity condition. For example, after receiving the target medication scheme information, the client may send an inventory data acquisition request of "metronidazole" produced by the manufacturer 2 and "omeprazole" produced by the manufacturer 3 to the drug inventory database, and receive inventory data of "metronidazole" produced by the manufacturer 2, which is sent by the drug inventory database, as 5, and inventory data of "omeprazole" produced by the manufacturer 3 as 3, that is, the pharmacy holds 5 parts of "metronidazole" produced by the manufacturer 2 and 3 parts of "omeprazole" produced by the manufacturer 3. In this case, the display interface of the client may display the first medication regimen including the "amoxicillin" and the "metronidazole" produced by the manufacturer 2, and the second medication regimen including the "amoxicillin", the "metronidazole" produced by the manufacturer 2, and the "omeprazole" produced by the manufacturer 3.
Please refer to fig. 2. The display interface of the client may include three information tables of "selected medicine", "medication proposal", "purchase order", and four functional controls of "add", "delete", "replace", and "order". The "selected medicine" information table may be used to display, among other things, the traceability code information, name information, quantity information, indication information, and price information of the medicine that the patient has selected. The medication proposal information table can be used for displaying the medication proposal, indication information corresponding to the medication proposal, adaptation group information and recommendation reason information included in the target medication proposal information received by the client. The "order for purchase" information table may be used to present order information for purchase formed from information in the "selected drug" information table, and may include order base information, drug information, payment information, medical insurance information, and member information. For example, information about "amoxicillin" selected by the patient may be displayed in the "selected drug" information table, and the first medication regimen including "amoxicillin" and "metronidazole" produced by manufacturer 2 and the second medication regimen including "amoxicillin", metronidazole "produced by manufacturer 2, and" omeprazole "produced by manufacturer 3 may be displayed in the" medication regimen advice "information table. After seeing the medication proposal displayed in the information table of the medication proposal, the salesperson of the pharmacy can inquire whether the related symptoms appear or not and whether the medication proposal is applicable or not according to the first and second corresponding indication information and the indication crowd information of the medication proposal, thereby confirming the final medication proposal, providing the proposal to the patient, and asking the patient to confirm whether the medicine is required to be purchased according to the medication proposal. For example, the indication 1 corresponding to the first medication regimen may be pharyngitis, the indication 2 corresponding to the second medication regimen may be gastrointestinal infection, and then a salesperson in a pharmacy may ask the patient whether symptoms of pharyngitis such as itching and sore throat, or symptoms of gastrointestinal infection such as abdominal pain, diarrhea and vomiting appear. After the patient confirms the occurrence of the abdominal pain symptoms, the pharmacy sales personnel may provide the patient with a second medication proposal as a medication proposal. After the patient confirms that the drug can be purchased according to the second medication regimen, the pharmacy sales personnel can click on the "add" functionality control to add the relevant information of "metronidazole" produced by manufacturer 2 and "omeprazole" produced by manufacturer 3 to the "selected drug" information table. At this time, the display interface can pop up a dialog box to prompt a salesman to operate the scanning device to scan the medicine traceability codes on the 'metronidazole' produced by the manufacturer 2 and the 'omeprazole' packing box produced by the manufacturer 3. After the operation of scanning the medicine traceability code is completed, a salesperson of a pharmacy can click on an order-placing function control so that medicine information in the selected medicine information table forms a medicine purchase order in the medicine purchase order information table. The patient pays for the order to purchase the drug successfully.
System architecture
Please refer to fig. 3. The embodiment of the specification provides a display system for medication scheme information. The presentation system of the medication information may include a client and a server. The number of clients and servers is not particularly limited in the present embodiment. The client and the server may be connected to each other via a wired or wireless network.
The client may be an electronic device having a network access function, a data storage function, and a display function. Specifically, for example, the client may be a desktop computer, a tablet computer, a notebook computer, a smart phone, a digital assistant, a smart wearable device, a smart television, or the like. Wherein, intelligent wearable device includes but is not limited to intelligent bracelet, intelligent wrist-watch, intelligent glasses, intelligent helmet etc.. Alternatively, the client may be a computer program with a man-machine interaction interface capable of running in the electronic device.
The server may be an electronic device with some arithmetic processing capability. In particular, the server may have a network communication module, a processor, a memory, and the like. A server may also refer to a computer program running in the electronic device. The server may also be a distributed server, or may be a system having multiple processors, memories, network communications modules, etc. operating in concert. Alternatively, the server may be a server cluster formed for several servers. Or, with the development of science and technology, the server may also be a new technical means capable of realizing the corresponding functions of the embodiment of the specification. For example, a new form of "server" based on quantum computing implementation may be possible.
Example method
Please refer to fig. 4. One embodiment of the present disclosure provides a method for displaying medication regimen information. The display method of the medication scheme information can be applied to the client. The display method of the medication scheme information can comprise the following steps.
Step S110: receiving medicine tracing code information; wherein, the medicine tracing code information corresponds to the medicine.
In this embodiment, the client may receive the drug traceability code information corresponding to the drug, where the drug traceability code information is standardized information, so as to determine the drug based on the standardized information, and improve the accuracy of the drug administration proposal to a certain extent.
In this embodiment, the drug traceability code may be used as an identification code of each drug, and the drug traceability code may be in one-to-one correspondence with each drug, where each drug is a minimum sales unit of the drug. Specifically, the medicine traceability code can be a digital code, a bar code, a two-dimensional code or any combination thereof. Alternatively, the drug tracking code may be another code that can be acquired by scanning or inputting by an external device. In this embodiment, the drug traceability code information may be a drug traceability code in a data format.
In this embodiment, the drug traceability code information is received, and the drug traceability code may be scanned by the user operating the external device or manually input by the user. Specifically, for example, a pharmacy salesperson may scan a drug traceability bar code on a drug packaging box through a radio frequency identification (Radio Frequency Identification, RFID) device, so that a client receives drug traceability code information.
Step S120: and sending a medication scheme acquisition request carrying the medicine tracing code information to a server so as to request the server to acquire target medication scheme information according to the standard information of the medicine corresponding to the medicine tracing code information.
In this embodiment, the medication scheme obtaining request carrying the standardized medication tracing code information may be sent to the server, so that the server may obtain the standard information of the medication identified by the medication tracing code information, and then obtain the target medication scheme information according to the standard information, where the standard information of the medication is also standardized information, so as to determine the target medication scheme information based on the standardized information, and further improve the accuracy of medication scheme suggestion.
In this embodiment, the medication regimen information may be used to represent a medication regimen. The dosage regimen may be used to represent the dosage and the dosage regimen that will achieve the specified therapeutic objectives. Specifically, the medication may include only one drug or may include multiple drugs. In the case where the regimen includes only one drug, the regimen may represent the dosage and the administration rule of the drug. For example, given that the therapeutic objective is anti-inflammatory, the corresponding regimen may be the dosage and regimen of amoxicillin. Where the regimen includes a plurality of drugs, the regimen may represent the combined dosage and the combined rules of the plurality of drugs. For example, if the specified therapeutic purpose is to treat pharyngitis, the corresponding medication may be the respective doses and rules of administration of amoxicillin and metronidazole, and the simultaneous administration of two drugs or the sequential order of administration of the two drugs.
In the present embodiment, the standard information of the medicine may be used to describe basic information that the medicine has. Wherein the label information may represent information that the drug does not change as the dealer and retailer change. Specifically, the standard information of the medicine can include a traceability code, a common name, a component, a national standard word, an indication, a use instruction and the like of the medicine.
In this embodiment, the target medication regimen information may include related medicine information having a specified association relationship with the standard information. The specified association relationship can be used for indicating that the associated medicine corresponding to the associated medicine information can be applied to the specified treatment purpose together with the medicine corresponding to the medicine traceability code information. The associated drug information may be label information of the associated drug, i.e., the associated drug information may be used to represent a traceability code, a common name, a composition, a national drug standard, an indication, instructions for use, etc. of the associated drug.
In this embodiment, the medication scheme obtaining request carrying the drug traceability code information is sent to the server, and the medication scheme obtaining request carrying the drug traceability code information can be constructed first and then sent to the server. The medicine tracing code information is added into the medicine scheme acquisition request data packet. The drug traceability code information and the drug regimen acquisition instruction can be encoded together to form a drug regimen acquisition request.
Step S130: and displaying the received target medication scheme information sent by the server.
In this embodiment, the received target medication scheme information sent by the server may be displayed to a salesman of the pharmacy, so that the salesman of the pharmacy may provide medication scheme advice for the patient according to the target medication scheme information.
In this embodiment, the received target medication scheme information sent by the server may be displayed directly through a display interface of the client. Specifically, for example, the first medication scheme and the second medication scheme in the above embodiment may be directly displayed on the display interface of the client, where no sequence exists between the first medication scheme and the second medication scheme.
In some embodiments, in the case that the target medication scheme information may represent a plurality of medication schemes, the received target medication scheme information sent by the server may be displayed, or the plurality of medication schemes represented by the target medication scheme information may be sorted by first adopting a specified sorting rule, and then the plurality of medication schemes may be displayed in the sorted order. Specifically, the specified ordering rules may be determined based on historical sales data, drug price data, and drug offer data. For example, the specified ordering rules may be determined based solely on historical sales data, with medication orders that are more historical sales being ranked higher. Alternatively, the specified ordering rule may be determined based solely on the drug price data, and the drug price sum for each drug regimen may be calculated, the closer the drug price sum is to the front of the drug regimen ordering for the drug price previously selected by the patient. Alternatively, the specified ordering rule may be determined based on only the medicine preference data, and the medicine preference price sum of each medicine regimen may be calculated, with the medicine regimen ordering earlier with a larger medicine preference price sum. Alternatively, the historical sales data, the drug price data, and the drug preference data may be given corresponding weights, respectively, the historical sales data, the drug price data, and the drug preference data for each medication scheme may be scored, and the weighted score for each medication scheme may be calculated, with higher scores leading to higher orders of medication schemes.
In the embodiment of the specification, the medicine traceability code information is received, the medicine scheme acquisition request carrying the medicine traceability code information is sent to the server, so that the server is required to acquire target medicine scheme information according to the medicine standard information corresponding to the medicine traceability code information, the target medicine scheme information fed back by the server is displayed to a salesperson of a pharmacy, the medicine purchased by a patient is determined according to the medicine traceability code information corresponding to the medicine, and the target medicine scheme information comprising related medicines which can be applied to a specified treatment purpose together with the medicine is acquired according to the medicine standard information.
In some embodiments, displaying the received target medication regimen information sent by the server may include: displaying the target medication scheme information under the condition that inventory data of related medicines related to the target medication scheme information meets the specified quantity condition; wherein the specified quantity condition includes that the quantity of the drug indicated by the inventory data of the associated drug is greater than the quantity of the drug included in the target medication regimen information.
In some cases, the associated drug to which the target medication information pertains may have been sold, and "no drug available" situations may occur if the pharmacy sales personnel still provide the target medication information to the patient as a medication advice. To reduce the possibility of such a situation, screening conditions may be set for the target medication regimen information, only the target medication regimen information satisfying the screening conditions being displayed.
In this embodiment, inventory data for the associated drug may be used to represent the inventory quantity of the associated drug that the pharmacy may sell. Specifically, the client may manage a drug inventory database in which the inventory amounts of all drugs that can be sold by the pharmacy are stored. After receiving the target medication scheme information sent by the server, the client can determine the associated medicine related to the target medication scheme information according to the associated medicine information in the target medication scheme information. The client may then obtain inventory data for the associated drug by accessing the drug inventory database. And under the condition that the inventory data of the related medicines meet the specified quantity conditions, displaying the target medication scheme information on a display interface of the client. The specified quantity condition includes that the quantity of the drug indicated by the inventory data of the associated drug is greater than the quantity of the drug included in the target medication regimen information. Thus, the displayed target medication scheme information can be sold by a pharmacy.
In some embodiments, inventory data for the associated drug may also be stored at other servers or cloud. After determining the related medicine related to the target medication scheme information, the client can acquire the inventory data of the related medicine by sending a data acquisition request to a server or cloud end which stores the inventory data of the related medicine.
In some embodiments, the step of displaying the received target medication regimen information sent by the server may include: and displaying corresponding indication information corresponding to the target medication scheme information.
The target medication regime information may represent one or more medication regimes. In the case where the target medication regimen information represents only one medication regimen, indication information corresponding to the medication regimen may be displayed on a display interface for assisting a pharmacy sales person in communicating with the patient to determine whether the medication regimen is applicable to the patient's actual condition. Under the condition that the target medication scheme information represents a plurality of medication schemes, indication information corresponding to each of the plurality of medication schemes can be displayed on a display interface so as to assist a salesperson of a pharmacy to communicate with a patient, thereby providing medication scheme suggestions for the patient, wherein the medication scheme suggestions are more accurately applicable to actual symptoms of the patient.
In this embodiment, indication information may be used to indicate the condition for which the drug in the targeted regimen is applicable and the common symptoms of that condition. Specifically, taking the first medication scheme in the above embodiment as an example, the indication of the medication scheme including "amoxicillin" and "metronidazole" may be pharyngitis, and the indication information corresponding to the first medication scheme may include: pharyngitis, cough, pharyngalgia, and itching of the pharynx. Please refer to fig. 2. In the "medication proposal" information table of the display interface, the corresponding indication information can be displayed corresponding to the medication one.
In some embodiments, the step of displaying the received target medication regimen information sent by the server may further include: and displaying corresponding adaptive crowd information and/or recommendation reason information corresponding to the target medication scheme information.
In this embodiment, the adapted population information may be used to represent the type of patient for whom the targeted regimen is applicable to treat the condition represented by the indication information. Specifically, taking the first medication scheme in the above embodiment as an example, the corresponding adaptive crowd information including "amoxicillin" and "metronidazole" for treating "pharyngitis" may indicate that the child, adult patient and elderly patient are suitable, but the pregnant woman, lactating woman, child and elderly patient should be cautious.
In this embodiment, the recommended cause information may be used to indicate the effect that the drug in the target medication regimen plays in treating the condition indicated by the indication information and the therapeutic effect that may be produced. Specifically, taking the first medication scheme in the above embodiment as an example, the recommended reason information for treating the pharyngitis by adopting the medication scheme including amoxicillin and metronidazole may indicate that amoxicillin can effectively treat gram-positive bacterial infection, metronidazole can effectively treat most anaerobic bacterial infection, and the combined medication of two antibiotics may be mutually supplemented, thereby improving the anti-inflammatory effect.
In some embodiments, the method for displaying medication information may further include: and providing a replacement function control in the display interface under the condition that the target medication scheme information does not comprise the medicine information of the medicine corresponding to the medicine tracing code information, so as to replace the medicine information of the medicine corresponding to the medicine tracing code information in the information table with the medicine information of the related medicine included in the target medication scheme information under the condition that the replacement function control is triggered.
In some cases, the target medication scheme information may not include the medication information of the drug selected by the patient, and if the patient receives the medication scheme suggestion of the salesman, the salesman needs to click on the "delete" function control first, delete the medication information of the drug previously selected by the patient in the "selected drug" information table, click on the "add" function control, and add the medication information of the associated drug in the medication scheme received by the patient to the "selected drug" information table. In order to simplify the operation of the salesman in the pharmacy and shorten the time for completing the medicine sales process, a replacement function control can be arranged on a display interface to realize a one-key replacement function.
Please refer to fig. 2. In this embodiment, the display interface of the client may have an information table for displaying medicine information of the selected purchased medicine. Specifically, the display interface of the client can display the medicine information of the selected medicine through the medicine information table. And under the condition that the target medication scheme information comprises the medicine information of the medicine corresponding to the medicine traceability code information, a salesperson of a pharmacy can add the medicine information of the associated medicine in the medication scheme received by the patient into a selected medicine information table by clicking an increasing function control. Under the condition that the target medication scheme information does not comprise the medicine information of the medicine corresponding to the medicine tracing code information, a salesperson of a pharmacy can directly replace the medicine information of the medicine corresponding to the medicine tracing code information in the medicine information table of the selected medicine by the medicine information of the related medicine in the medication scheme received by a patient by clicking a replacement function control.
Referring to fig. 5, an embodiment of the present disclosure provides a method for sending medication information. The method for sending the medication scheme information can be applied to a server. The transmission method of the medication information may include the following steps.
Step S210: receiving a medication scheme acquisition request carrying medication traceability code information sent by a client; wherein, the medicine tracing code information corresponds to the medicine.
In this embodiment, the server may receive a medication scheme acquisition request carrying medication traceability code information sent by the client, where the medication traceability code information is standardized information, so as to achieve acquisition of target medication scheme information based on the standardized information, and improve accuracy of medication scheme suggestion to a certain extent.
In this embodiment, the receiving the medication scheme obtaining request with the medication traceability code information sent by the client may directly receive the medication scheme obtaining request sent by the client to the server, or the client may first send the medication scheme obtaining request to the relay server, where the server receives the medication scheme obtaining request forwarded by the relay server.
Step S220: and acquiring target medication scheme information according to the label information of the medicine corresponding to the medicine tracing code information.
In this embodiment, the server may obtain the standard information of the drug identified by the drug traceability code information, and then obtain the target medication scheme information according to the standard information, where the standard information of the drug is also standardized information, so as to determine the target medication scheme information based on the standardized information, and further improve the accuracy of medication scheme suggestion.
In this embodiment, a medication schedule information base may be established in correspondence with the standard information of the medicine or part of the information in the standard information. The medication intake scheme information base may be managed by other servers or cloud servers. And acquiring target medication scheme information according to the standard information of the medicine corresponding to the medicine traceability code information, and receiving the medication scheme information sent by other servers or cloud servers by sending a medication scheme acquisition request carrying the standard information or part of the standard information to the other servers or cloud servers managing the medication scheme information base, wherein the medication scheme information is used as target medication scheme information. Specifically, the server may first construct a medication scheme acquisition request carrying the standard information of the drug corresponding to the drug traceability code information or part of information of the standard information, and then send the medication scheme acquisition request to other servers or cloud servers. The drug scheme acquisition request carrying the drug label information corresponding to the drug traceability code information or part of information of the drug label information is constructed, and the drug scheme acquisition request data packet sent by the client can be directly added with the label information. The drug regimen acquisition request sent by the client can be decoded, and the standard information, the drug traceability code information and the drug regimen acquisition instruction are encoded together to form the drug regimen acquisition request.
In some embodiments, a machine learning model for generating medication regimen information from partial information in the drug's label information may be trained in advance. And acquiring target medication scheme information according to the standard information of the medicine corresponding to the medicine traceability code information, extracting part of information in the standard information, inputting the extracted part of information into a machine learning model, and taking an output result of the machine learning model as the target medication scheme information. Specifically, for example, the label information of a drug may be used to indicate a traceability code, a common name, a component, a national standard, an indication, a usage instruction, and the like of the drug. Information indicating the general name, composition, indication, and instruction of use of the drug may be extracted from the standard information, and the extracted information may be input into a neural network model trained in advance, with the output result of the neural network model being the target medication regimen information.
Step S230: and sending the target medication scheme information to the client.
In this embodiment, the target medication information may be sent to the client, so that the client may display the target medication information to a salesman of a pharmacy, and the salesman of the pharmacy may provide medication advice for the patient according to the target medication information.
In the embodiment of the specification, the server receives the medication scheme acquisition request carrying the medicine tracing code information, acquires the target medication scheme information according to the standard information of the medicine corresponding to the medicine tracing code information, and then sends the target medication scheme information to the client for displaying the target medication information to the sales staff of the pharmacy by the client, so that the medicine purchased by the patient is determined through the medicine tracing code information corresponding to the medicine, and then acquires the target medication scheme information comprising the related medicine which can be applied to the designated treatment purpose together with the medicine according to the standard information of the medicine.
In some embodiments, the step of obtaining the target medication scheme information according to the standard information of the medicine corresponding to the medicine traceability code information may include: acquiring the standard information of the medicine corresponding to the medicine tracing code information according to the medicine tracing code information; wherein the standard information may include indication information of the drug; and performing matching operation in the appointed medication scheme information set based on the indication information of the medicine to obtain target medication scheme information corresponding to the indication information of the medicine.
In the case of acquiring target medication information by sending a medication acquisition request carrying the standard information or part of the information in the standard information to another server or cloud server, there may be a network delay between the server and the other server or cloud server, resulting in that the server needs a long time to receive the medication information fed back by the other server or cloud server. In the case of acquiring the target medication regimen information by inputting part of the information in the standard information to the machine learning model trained in advance, the machine learning model may require a long time of operation to output the result. That is, obtaining the target medication regimen information in both of the above-described ways may take a long time. In order to shorten the time for acquiring the target medication scheme information and improve the efficiency of acquiring the target medication scheme information, the target medication scheme information can be obtained by performing matching operation in the designated medication scheme information set according to part of information in the standard information.
In this embodiment, the drug label information may be stored in a drug label information base. The server may manage a pharmaceutical standard information base. And acquiring the standard information of the medicine corresponding to the medicine tracing code information according to the medicine tracing code information, and inquiring in a medicine standard information base according to the medicine tracing code information to acquire the standard information.
In the present embodiment, the specified medication information set may include a plurality of medication information and indication information corresponding to the medication information. The specified medication information set may be stored in a medication information set database, which may be managed by the server.
In this embodiment, the specified medication information set may be generated from historical sales data. Specifically, the common name information and the indication information of the drug can be extracted from the standard information of the drug, the matching is performed in the historical sales data based on the common name information and the indication information, and the matching result is used as the appointed medication scheme information set.
In this embodiment, the matching operation is performed in the specified medication information set based on the indication information of the drug, and the indication information of the drug may be extracted from the standard information of the queried drug, and then the medication information set database is accessed, and the matching result is used as the target medication information based on the indication information and matching is performed in the specified medication information set.
In some embodiments, the method for sending the medication regimen information may further include: generating the appointed medication scheme information set according to attribute data which are extracted from the pharmaceutical knowledge graph and represent a plurality of dimension attributes of the medicine; wherein the attribute data includes, but is not limited to, any of the following and combinations thereof: basic information of medicines, indication information, cooperative treatment effect information among medicines, drug resistance information, medicine dosage influence information, toxic and side effect information, medication suggestion information and medication contraindication information.
In the case where the specified medication information set is generated based on the historical sales data, since the historical sales data can reflect only the historical sales medication plan information of the medicine when applied to the indication, the historical sales medication plan information may be error information, which is not actually applicable to the indication. To improve the accuracy and specificity of medication regimen recommendations, a set of specified medication regimen information may be generated based on a pharmaceutical knowledge graph.
In the present embodiment, the basic information of the medicine may include common name information, component information, appearance information, storage information, and the like of the medicine.
In the present embodiment, the indication information of the medicine may include information of a disorder to which the medicine is applied, information of a causative factor causing the disorder, information of a common symptom of the disorder, and the like.
In the present embodiment, the inter-drug cooperative therapy action information may include common name information of other drugs that can be cooperative-treated with the drug, common name information of other drugs that cannot be cooperative-treated with the drug, disease information to which the drug and other drugs are applied in cooperative treatment, influence information of other drugs on the drug efficacy, and the like.
In the present embodiment, the drug resistance information may include cause information of the possibility of occurrence of drug resistance, judgment information of whether or not drug resistance is generated, countermeasure information after the occurrence of drug resistance, and the like.
In the present embodiment, the drug dose influence information may include main dosage form or specification information of the drug, onset time information, efficacy maintenance time information, countermeasure information for missing the drug, countermeasure information for overdosing, and the like of the drug.
In the present embodiment, the drug toxic and side effect information may include adverse effect information that may be generated by using the drug alone, adverse effect information that may be generated by co-therapy of the drug with other drugs, countermeasure information after occurrence of adverse effect, and the like.
In the present embodiment, the medication advice information may include patient information for which the medication is applied, patient information for which the medication is cautiously applied, specific usage amount information for different types of patients, and the like.
In the present embodiment, the medication contraindication information may include patient information for disabling the medication, countermeasure information for disabling misuse of the medication by the patient for disabling the medication, and the like.
In this embodiment, a machine learning model for evaluating and sorting multidimensional attribute data of a drug may be trained in advance, multidimensional attribute data of a drug may be input to the machine learning model, and the machine learning model may output a prescribed number of medication regimen information in the order of the front. Specifically, for example, the machine learning model may be a convolutional neural network (Convolutional Neural Networks, CNN) model.
In this embodiment, the specified medication plan information set is generated from attribute data representing a plurality of dimension attributes of the drug extracted from the pharmaceutical knowledge graph, and the specified medication plan information set may be determined by manually auditing an output result of the machine learning model. Specifically, the general name information of the drug can be extracted from the standard information of the drug corresponding to the drug traceability code information, then the attribute data representing a plurality of dimension attributes of the drug is extracted from the pharmaceutical knowledge graph based on the general name information of the drug, the extracted attribute data is input into a machine learning model for evaluating the multidimensional attribute data of the drug, and the output result of the machine learning model is used as candidate medication scheme information of the drug. And then, the candidate medicine scheme information of the medicine can be submitted to an expert with higher medicine knowledge level for auditing, the expert can select medicine scheme information which accords with clinical medicine principles from the candidate medicine scheme information as recommended medicine scheme information, and the medicine principle information and typical symptom information are added into the recommended medicine scheme information according to indication information corresponding to the recommended medicine scheme information, and a specified medicine scheme information set is formed by a plurality of recommended medicine scheme information.
Example apparatus, electronic device, storage Medium, and software
Please refer to fig. 6. One embodiment of the present disclosure further provides a device for displaying medication information. The display device of the medication scheme information may include: the device comprises a receiving module, a sending module and a display module.
The receiving module is used for receiving the medicine tracing code information; wherein, the medicine tracing code information corresponds to the medicine.
The sending module is used for sending a medication scheme acquisition request carrying the medicine tracing code information to a server so as to request the server to acquire target medication scheme information according to the standard information of the medicine corresponding to the medicine tracing code information; the standard information is used for describing basic information of the medicine; the target medication scheme comprises associated medicine information with a specified association relation with the medicine information of the medicine; the appointed association relation is used for indicating that the associated medicine corresponding to the associated medicine information can be applied to the appointed treatment purpose together with the medicine corresponding to the medicine traceability code information.
The display module is used for displaying the received target medication scheme information sent by the server.
Please refer to fig. 7. One embodiment of the present specification also provides a device for transmitting medication regimen information. The transmission device of the medication information may include: the device comprises a receiving module, an acquiring module and a sending module.
The receiving module is used for receiving a medication scheme acquisition request carrying medicine traceability code information sent by the client; wherein, the medicine tracing code information corresponds to the medicine;
the acquisition module is used for acquiring target medication scheme information according to the standard information of the medicine corresponding to the medicine tracing code information; the standard information is used for describing basic information of the medicine; the target medication scheme information comprises associated medicine information with a specified association relation with the standard information; the appointed association relation is used for indicating that the associated medicine indicated by the associated medicine information can be applied to the appointed treatment purpose together with the medicine corresponding to the medicine traceability code information.
And the sending module is used for sending the target medication scheme information to the client.
Specific functions and effects achieved by the display device for medication information or the sending device for medication information may be explained with reference to other embodiments of the present specification, and are not described herein. The display device of the medication scheme information or the sending device of the medication scheme information can be all or partially implemented by software, hardware and combinations thereof. The modules can be embedded in hardware or independent of a processor in the computer equipment, and can also be stored in a memory in the computer equipment in a software mode, so that the processor can call and execute the operations corresponding to the modules.
Please refer to fig. 8. The embodiment of the present disclosure further provides a computer device, including a memory and a processor, where the memory stores a computer program, and the processor executes the computer program to implement the method for displaying the medication plan information or the method for sending the medication plan information in any of the foregoing embodiments.
The present specification also provides a computer-readable storage medium having stored thereon a computer program which, when executed by a computer, causes the computer to execute the presentation method of medication program information or the transmission method of medication program information in any of the above embodiments.
The present disclosure also provides a computer program product containing instructions that, when executed by a computer, cause the computer to perform the method for displaying or the method for transmitting medication information according to any of the above embodiments.
User information or user account information (including but not limited to user device information, user personal information, etc.) and data (including but not limited to data for analysis, stored data, presented data, etc.) referred to in various embodiments of the present description are both user-authorized or fully authorized information and data by parties, and the collection, use and processing of relevant data requires compliance with relevant legal regulations and standards of relevant countries and regions, and is provided with corresponding operation portals for user selection of authorization or denial.
It will be appreciated that the specific examples herein are intended only to assist those skilled in the art in better understanding the embodiments of the present disclosure and are not intended to limit the scope of the present invention.
It should be understood that, in various embodiments of the present disclosure, the sequence number of each process does not mean that the execution sequence of each process should be determined by the function and the internal logic, and should not constitute any limitation on the implementation process of the embodiments of the present disclosure.
It will be appreciated that the various embodiments described in this specification may be implemented either alone or in combination, and are not limited in this regard.
Unless defined otherwise, all technical and scientific terms used in the embodiments of this specification have the same meaning as commonly understood by one of ordinary skill in the art to which this specification belongs. The terminology used in the description is for the purpose of describing particular embodiments only and is not intended to limit the scope of the description. The term "and/or" as used in this specification includes any and all combinations of one or more of the associated listed items. As used in this specification and the appended claims, the singular forms "a," "an," and "the" are intended to include the plural forms as well, unless the context clearly indicates otherwise.
It will be appreciated that the processor of the embodiments of the present description may be an integrated circuit chip having signal processing capabilities. In implementation, the steps of the above method embodiments may be implemented by integrated logic circuits of hardware in a processor or instructions in software form. The processor may be a general purpose processor, a digital signal processor (Digital Signal Processor, DSP), an application specific integrated circuit (Application Specific Integrated Circuit, ASIC), an off-the-shelf programmable gate array (Field Programmable Gate Array, FPGA) or other programmable logic device, discrete gate or transistor logic device, discrete hardware components. The methods, steps and logic blocks disclosed in the embodiments of the present specification may be implemented or performed. A general purpose processor may be a microprocessor or the processor may be any conventional processor or the like. The steps of a method disclosed in connection with the embodiments of the present specification may be embodied directly in hardware, in a decoded processor, or in a combination of hardware and software modules in a decoded processor. The software modules may be located in a random access memory, flash memory, read only memory, programmable read only memory, or electrically erasable programmable memory, registers, etc. as well known in the art. The storage medium is located in a memory, and the processor reads the information in the memory and, in combination with its hardware, performs the steps of the above method.
It will be appreciated that the memory in the embodiments of this specification may be either volatile memory or nonvolatile memory, or may include both volatile and nonvolatile memory. The nonvolatile memory may be a read-only memory (ROM), a Programmable ROM (PROM), an Erasable Programmable ROM (EPROM), an Electrically Erasable Programmable ROM (EEPROM), or a flash memory, among others. The volatile memory may be Random Access Memory (RAM). It should be noted that the memory of the systems and methods described herein is intended to comprise, without being limited to, these and any other suitable types of memory.
Those of ordinary skill in the art will appreciate that the elements and algorithm steps described in connection with the embodiments disclosed herein can be implemented as electronic hardware, or combinations of computer software and electronic hardware. Whether such functionality is implemented as hardware or software depends upon the particular application and design constraints imposed on the solution. Skilled artisans may implement the described functionality in varying ways for each particular application, but such implementation decisions should not be interpreted as causing a departure from the scope of the present specification.
It will be clear to those skilled in the art that, for convenience and brevity of description, specific working procedures of the above-described system, apparatus and unit may refer to corresponding procedures in the foregoing method embodiments, and are not repeated herein.
In the several embodiments provided in this specification, it should be understood that the disclosed systems, apparatuses, and methods may be implemented in other ways. For example, the apparatus embodiments described above are merely illustrative, e.g., the division of the units is merely a logical function division, and there may be additional divisions when actually implemented, e.g., multiple units or components may be combined or integrated into another system, or some features may be omitted or not performed. Alternatively, the coupling or direct coupling or communication connection shown or discussed with each other may be an indirect coupling or communication connection via some interfaces, devices or units, which may be in electrical, mechanical or other form.
The units described as separate units may or may not be physically separate, and units shown as units may or may not be physical units, may be located in one place, or may be distributed on a plurality of network units. Some or all of the units may be selected according to actual needs to achieve the purpose of the embodiment.
In addition, each functional unit in each embodiment of the present specification may be integrated into one processing unit, each unit may exist alone physically, or two or more units may be integrated into one unit.
The functions, if implemented in the form of software functional units and sold or used as a stand-alone product, may be stored in a computer-readable storage medium. Based on this understanding, the technical solutions of the present specification may be essentially or portions contributing to the prior art or portions of the technical solutions may be embodied in the form of a software product stored in a storage medium, including several instructions to cause a computer device (which may be a personal computer, a server, or a network device, etc.) to perform all or part of the steps of the methods described in the embodiments of the present specification. And the aforementioned storage medium includes: a usb disk, a removable hard disk, a read-only memory (ROM), a random-access memory (RAM), a magnetic disk, or an optical disk, etc.
The foregoing is merely specific embodiments of the present disclosure, but the scope of the present disclosure is not limited thereto, and any person skilled in the art can easily think about changes or substitutions within the technical scope disclosed in the present disclosure, and should be covered by the scope of the present disclosure. Therefore, the protection scope of the present invention shall be subject to the protection scope of the claims.
Claims (11)
1. A method for displaying medication information, which is applied to a client, the method comprising:
receiving medicine tracing code information; wherein, the medicine tracing code information corresponds to the medicine;
sending a medication scheme acquisition request carrying the medicine tracing code information to a server, wherein the medication scheme acquisition request is used for requesting the server to acquire target medication scheme information according to the standard information of the medicine corresponding to the medicine tracing code information; the standard information is used for describing basic information of the medicine; the target medication scheme information comprises associated medicine information with a specified association relation with the standard information; the appointed association relation is used for indicating that the associated medicine corresponding to the associated medicine information can be applied to the appointed treatment purpose together with the medicine corresponding to the medicine traceability code information;
and displaying the received target medication scheme information sent by the server.
2. The method of claim 1, wherein the step of presenting the received target medication regime information sent by the server comprises:
displaying the target medication scheme information under the condition that inventory data of related medicines related to the target medication scheme information meets the specified quantity condition; wherein the specified quantity condition includes that the quantity of the drug indicated by the inventory data of the associated drug is greater than the quantity of the drug included in the target medication regimen information.
3. The method of claim 1, wherein the step of presenting the received target medication regime information sent by the server comprises:
and displaying corresponding indication information corresponding to the target medication scheme information.
4. The method of claim 1, wherein the display interface of the client has an information table for displaying drug information of the selected drug; the method further comprises the steps of:
and providing a replacement function control in the display interface under the condition that the target medication scheme information does not comprise the medicine information of the medicine corresponding to the medicine tracing code information, so as to replace the medicine information of the medicine corresponding to the medicine tracing code information in the information table with the medicine information of the related medicine included in the target medication scheme information under the condition that the replacement function control is triggered.
5. A method for transmitting medication information, the method being applied to a server, the method comprising:
receiving a medication scheme acquisition request carrying medication traceability code information sent by a client; wherein, the medicine tracing code information corresponds to the medicine;
acquiring target medication scheme information according to the label information of the medicine corresponding to the medicine tracing code information; the standard information is used for describing basic information of the medicine; the target medication scheme information comprises associated medicine information with a specified association relation with the standard information; the appointed association relation is used for indicating that the associated medicine corresponding to the associated medicine information can be applied to the appointed treatment purpose together with the medicine corresponding to the medicine traceability code information;
And sending the target medication scheme information to the client.
6. The method of claim 5, wherein the step of obtaining the target medication regimen information based on the drug label information corresponding to the drug traceability code information comprises:
acquiring the standard information of the medicine corresponding to the medicine tracing code information according to the medicine tracing code information; wherein the standard information includes indication information of the drug;
performing matching operation in a specified medication scheme information set based on the indication information of the medicine to obtain target medication scheme information corresponding to the indication information of the medicine; the appointed medication scheme information set comprises a plurality of medication scheme information and indication information corresponding to the medication scheme information.
7. The method of claim 5, wherein the method further comprises:
generating the appointed medication scheme information set according to attribute data which are extracted from the pharmaceutical knowledge graph and represent a plurality of dimension attributes of the medicine; wherein the attribute data includes, but is not limited to, any of the following and combinations thereof: basic information of medicines, indication information, cooperative treatment effect information among medicines, drug resistance information, medicine dosage influence information, toxic and side effect information, medication suggestion information and medication contraindication information.
8. A presentation device for medication information, the device being applied to a client, the device comprising:
the receiving module is used for receiving the medicine tracing code information; wherein, the medicine tracing code information corresponds to the medicine;
the sending module is used for sending a medication scheme acquisition request carrying the medicine tracing code information to a server so as to request the server to acquire target medication scheme information according to the standard information of the medicine corresponding to the medicine tracing code information; the standard information is used for describing basic information of the medicine; the target medication scheme comprises associated medicine information with a specified association relation with the standard information; the appointed association relation is used for indicating that the associated medicine corresponding to the associated medicine information can be applied to the appointed treatment purpose together with the medicine corresponding to the medicine traceability code information;
and the display module is used for receiving and displaying the target medication scheme information sent by the server.
9. A transmission device of medication information, characterized in that the device is applied to a server, and the device comprises:
the receiving module is used for receiving a medication scheme acquisition request carrying medicine traceability code information sent by the client; wherein, the medicine tracing code information corresponds to the medicine;
The acquisition module is used for acquiring target medication scheme information according to the standard information of the medicine corresponding to the medicine tracing code information; the standard information is used for describing basic information of the medicine; the target medication scheme information comprises associated medicine information with a specified association relation with the standard information; the appointed association relation is used for indicating that the associated medicine indicated by the associated medicine information can be applied to the appointed treatment purpose together with the medicine corresponding to the medicine traceability code information;
and the sending module is used for sending the target medication scheme information to the client.
10. A computer device comprising a memory storing a computer program and a processor implementing the method of any one of claims 1 to 7 when the computer program is executed by the processor.
11. A computer readable storage medium having stored thereon a computer program which, when executed by a processor, implements the method of any of claims 1 to 7.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202310518684.3A CN116705224A (en) | 2023-05-09 | 2023-05-09 | Display method, device, equipment and medium of medication scheme information |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202310518684.3A CN116705224A (en) | 2023-05-09 | 2023-05-09 | Display method, device, equipment and medium of medication scheme information |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN116705224A true CN116705224A (en) | 2023-09-05 |
Family
ID=87844205
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202310518684.3A Pending CN116705224A (en) | 2023-05-09 | 2023-05-09 | Display method, device, equipment and medium of medication scheme information |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN116705224A (en) |
-
2023
- 2023-05-09 CN CN202310518684.3A patent/CN116705224A/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Ahearn et al. | General practitioners' perceptions of the pharmaceutical decision‐support tools in their prescribing software | |
| US8548828B1 (en) | Method, process and system for disease management using machine learning process and electronic media | |
| Díaz-Ordaz et al. | Are missing data adequately handled in cluster randomised trials? A systematic review and guidelines | |
| CN112700838A (en) | Big data-based medication scheme recommendation method and device and related equipment | |
| US8630873B1 (en) | Systems and methods for shifting prescription market share by presenting pricing differentials for therapeutic alternatives | |
| US8670991B2 (en) | Authenticating prescriber identity to enable electronically ordering drug samples from a drug sample fulfillment platform | |
| US8046242B1 (en) | Systems and methods for verifying prescription dosages | |
| US10496793B1 (en) | Systems and methods for determining eligibility in a prescription safety network program | |
| US20120179481A1 (en) | Recommending Prescription Information | |
| US20050228593A1 (en) | Method, system, and computer program for providing and evaluating medicine information | |
| CN106202893A (en) | Method recommended by a kind of medicine | |
| CN101432772A (en) | Method for competitive prescription drug and/or bidding service provider slection | |
| US8392219B1 (en) | Systems and methods for streamlined patient enrollment for one or more healthcare programs | |
| KR20120096647A (en) | A service providing method for customized medical information sales | |
| KR102493374B1 (en) | Family Health Management Service System And the Method Using the Same | |
| CN113722371B (en) | Medicine recommendation method, device, equipment and storage medium based on decision tree | |
| CN109636652A (en) | Purchase monitoring method, monitoring service end and the storage medium of medicine abnormal behavior | |
| Torres et al. | Identifying the commonly used antibiotics for self-medication in urban Mozambique: a qualitative study | |
| WO2023035618A1 (en) | Prescription generation method and apparatus based on natural language processing, and device and medium | |
| US20160321411A1 (en) | Systems and methods for providing consumer discounts on compounded prescription medications | |
| Hung et al. | The impact of a medication reconciliation programme at geriatric hospital admission: A pre‐/postintervention study | |
| CN114974530A (en) | Post-diagnosis follow-up method, system and storage medium | |
| US20230129327A1 (en) | Apparatus for providing customized nutritional supplement information and operation method thereof | |
| CN116705224A (en) | Display method, device, equipment and medium of medication scheme information | |
| KR20200076397A (en) | Method creating sharing database |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |